Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-01 @ 1:03 AM
Study NCT ID:
NCT02994056
Status:
COMPLETED
Last Update Posted:
2020-03-02
First Post:
2016-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-13
First Submit QC Date:
None
Study First Post Date:
2016-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-17
Results First Submit QC Date:
None
Results First Post Date:
2019-10-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-03-02
Last Update Post Date Type:
ACTUAL